Remotely Controlled Chemomagnetic Modulation of Targeted Neural Circuits

Connecting neural circuit output to behaviour can be facilitated by the precise chemical manipulation of specific cell populations1,2. Engineered receptors exclusively activated by designer small molecules enable manipulation of specific neural pathways3,4. However, their application to studies of behaviour has thus far been hampered by a trade-off between the low temporal resolution of systemic injection versus the invasiveness of implanted cannulae or infusion pumps2. Here, we developed a remotely controlled chemomagnetic modulation—a nanomaterials-based technique that permits the pharmacological interrogation of targeted neural populations in freely moving subjects. The heat dissipated by magnetic nanoparticles (MNPs) in the presence of alternating magnetic fields (AMFs) triggers small-molecule release from thermally sensitive lipid vesicles with a 20 s latency. Coupled with the chemogenetic activation of engineered receptors, this technique permits the control of specific neurons with temporal and spatial precision. The delivery of chemomagnetic particles to the ventral tegmental area (VTA) allows the remote modulation of motivated behaviour in mice. Furthermore, this chemomagnetic approach activates endogenous circuits by enabling the regulated release of receptor ligands. Applied to an endogenous dopamine receptor D1 (DRD1) agonist in the nucleus accumbens (NAc), a brain area involved in mediating social interactions, chemomagnetic modulation increases sociability in mice. By offering a temporally precise control of specified ligand–receptor interactions in neurons, this approach may facilitate molecular neuroscience studies in behaving organisms.Controlled delivery of neuromodulators in the brain might improve the understanding of the molecular basis of behaviour. In this letter, magnetic liposomes injected in deep brain regions release small molecules under remote magnetic stimulation, activating specific neuronal circuits in freely moving mice.

[1]  Hanyi Zhuang,et al.  Ephrin-B3 coordinates timed axon targeting and amygdala spinogenesis for innate fear behaviour , 2016, Nature Communications.

[2]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[3]  R Blumenthal,et al.  Design of liposomes for enhanced local release of drugs by hyperthermia. , 1978, Science.

[4]  B. Roth.  DREADDs for Neuroscientists , 2016, Neuron.

[5]  R. Harris-Warrick,et al.  Modulation of neural networks for behavior. , 1991, Annual review of neuroscience.

[6]  Jonathan S. Dordick,et al.  Radio-Wave Heating of Iron Oxide Nanoparticles Can Regulate Plasma Glucose in Mice , 2012, Science.

[7]  Hanqing Zhang,et al.  ToxId: an efficient algorithm to solve occlusions when tracking multiple animals , 2017, Scientific Reports.

[8]  Kyle S. Smith,et al.  Dreadds: Use and Application in Behavioral Neuroscience Section 1: Advantages for Behavioral Neuroscience Dreadds Involve the Use of Receptor Proteins Derived from Targeted Mutagenesis of Endogenous G-protein Coupled Receptor , 2022 .

[9]  Ali Khademhosseini,et al.  Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[10]  T. Curran,et al.  Expression of c-fos protein in brain: metabolic mapping at the cellular level. , 1988, Science.

[11]  Raag D. Airan,et al.  Natural Neural Projection Dynamics Underlying Social Behavior , 2014, Cell.

[12]  Polina Anikeeva,et al.  Practical methods for generating alternating magnetic fields for biomedical research. , 2017, The Review of scientific instruments.

[13]  L. Lo,et al.  Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release , 2009, Nanotechnology.

[14]  C. Bárcena,et al.  APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE , 2003 .

[15]  Polina Anikeeva,et al.  Wireless magnetothermal deep brain stimulation , 2015, Science.

[16]  Heng Huang,et al.  Remote control of ion channels and neurons through magnetic-field heating of nanoparticles. , 2010, Nature nanotechnology.

[17]  M. G. Christiansen,et al.  Magnetically Multiplexed Heating of Single Domain Nanoparticles , 2014, 1403.1535.

[18]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[19]  Elyssa B. Margolis,et al.  Ventral tegmental area: cellular heterogeneity, connectivity and behaviour , 2017, Nature Reviews Neuroscience.

[20]  B. Roth,et al.  Chemogenetic tools to interrogate brain functions. , 2014, Annual review of neuroscience.

[21]  Robert Langer,et al.  Miniaturized neural system for chronic, local intracerebral drug delivery , 2018, Science Translational Medicine.

[22]  Magnus Andersson,et al.  ToxTrac: A fast and robust software for tracking organisms , 2017, ArXiv.

[23]  Brenda C. Shields,et al.  Deconstructing behavioral neuropharmacology with cellular specificity , 2017, Science.

[24]  Aaron S. Andalman,et al.  Dopamine neurons modulate neural encoding and expression of depression-related behaviour , 2012, Nature.

[25]  E. Nestler.  Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[26]  A. Misra,et al.  Drug delivery to the central nervous system: a review. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[27]  K. Deisseroth,et al.  Input-specific control of reward and aversion in the ventral tegmental area , 2012, Nature.

[28]  W. Mcbride,et al.  D1–D2 dopamine receptor interaction within the nucleus accumbens mediates long‐loop negative feedback to the ventral tegmental area (VTA) , 2001, Journal of neurochemistry.

[29]  B. Roth,et al.  DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. , 2015, Annual review of pharmacology and toxicology.

[30]  Stefan R. Pulver,et al.  Ultra-sensitive fluorescent proteins for imaging neuronal activity , 2013, Nature.

[31]  M. G. Christiansen,et al.  Localized Excitation of Neural Activity via Rapid Magnetothermal Drug Release , 2016 .

[32]  Arnd Pralle,et al.  Magnetothermal genetic deep brain stimulation of motor behaviors in awake, freely moving mice , 2017, eLife.

[33]  L. Goodyear,et al.  Validity Assessment of 5 Day Repeated Forced-Swim Stress to Model Human Depression in Young-Adult C57BL/6J and BALB/cJ Mice , 2016, eNeuro.

[34]  M. G. Christiansen,et al.  Magnetically Actuated Protease Sensors for in Vivo Tumor Profiling. , 2016, Nano letters.

[35]  X. Jia,et al.  One-Step Optogenetics with Multifunctional Flexible Polymer Fibers , 2017, Nature Neuroscience.